Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Sabrina Uhrig"'
Autor:
Philipp Ziegler, Andreas D. Hartkopf, Markus Wallwiener, Lothar Häberle, Hans-Christian Kolberg, Peyman Hadji, Hans Tesch, Johannes Ettl, Diana Lüftner, Volkmar Müller, Laura L. Michel, Erik Belleville, Pauline Wimberger, Carsten Hielscher, Hanna Huebner, Sabrina Uhrig, Lena A. Wurmthaler, Carolin C. Hack, Christoph Mundhenke, Christian Kurbacher, Peter A. Fasching, Rachel Wuerstlein, Michael Untch, Wolfgang Janni, Florin-Andrei Taran, Michael P. Lux, Diethelm Wallwiener, Sara Y. Brucker, Tanja N. Fehm, Andreas Schneeweiss, Chloë Goossens
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-12 (2024)
Abstract Background Although adequate physical activity has been shown to be beneficial in early breast cancer, evidence in metastatic breast cancer is sparse and contradictory, which could be related to distinct effects of physical activity on the d
Externí odkaz:
https://doaj.org/article/f6addaf5728b4463afe3407a59ff7008
Autor:
Peter A. Fasching, Chunling Hu, Steven N. Hart, Matthias Ruebner, Eric C. Polley, Rohan D. Gnanaolivu, Andreas D. Hartkopf, Hanna Huebner, Wolfgang Janni, Peyman Hadji, Hans Tesch, Sabrina Uhrig, Johannes Ettl, Michael P. Lux, Diana Lüftner, Markus Wallwiener, Lena A. Wurmthaler, Chloë Goossens, Volkmar Müller, Matthias W. Beckmann, Alexander Hein, Daniel Anetsberger, Erik Belleville, Pauline Wimberger, Michael Untch, Arif B. Ekici, Hans-Christian Kolberg, Arndt Hartmann, Florin-Andrei Taran, Tanja N. Fehm, Diethelm Wallwiener, Sara Y. Brucker, Andreas Schneeweiss, Lothar Häberle, Fergus J. Couch
Publikováno v:
npj Breast Cancer, Vol 10, Iss 1, Pp 1-7 (2024)
Abstract Germline mutations in BRCA1 and BRCA2 (gBRCA1/2) are required for a PARP inhibitor therapy in patients with HER2-negative (HER2−) advanced breast cancer (aBC). However, little is known about the prognostic impact of gBRCA1/2 mutations in a
Externí odkaz:
https://doaj.org/article/7fc65e7d8ec9445caafcbb4945b9c522
Autor:
Peter A. Fasching, Alexander Hein, Hans-Christian Kolberg, Lothar Häberle, Sabrina Uhrig, Matthias Rübner, Erik Belleville, Carolin C. Hack, Tanja N. Fehm, Wolfang Janni, Arndt Hartmann, Ramona Erber, Anna-Katharin Theuser, Sara Y. Brucker, Andreas D. Hartkopf, Michael Untch
Publikováno v:
European Journal of Cancer. 184:1-9
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::df061dd591a8c2b5921376891fc37249
https://doi.org/10.1016/j.ejca.2023.01.001
https://doi.org/10.1016/j.ejca.2023.01.001
Autor:
Tobias Engler, Peter A. Fasching, Diana Lüftner, Andreas D. Hartkopf, Volkmar Müller, Hans-Christian Kolberg, Peyman Hadji, Hans Tesch, Lothar Häberle, Johannes Ettl, Markus Wallwiener, Matthias W. Beckmann, Alexander Hein, Erik Belleville, Sabrina Uhrig, Pauline Wimberger, Carsten Hielscher, Christian M. Kurbacher, Rachel Wuerstlein, Michael Untch, Florin-Andrei Taran, Hans-Martin Enzinger, Petra Krabisch, Manfred Welslau, Michael Maasberg, Dirk Hempel, Michael P. Lux, Laura L. Michel, Wolfgang Janni, Diethelm Wallwiener, Sara Y. Brucker, Tanja N. Fehm, Andreas Schneeweiss
Publikováno v:
Senologie - Zeitschrift für Mammadiagnostik und -therapie. 20:43-56
Zusammenfassung Hintergrund Umfangreiche Daten aus prospektiven klinischen Studien liefern einen hohen Evidenzgrad für den Einsatz von CDK4/6-Hemmern in Kombination mit einer endokrinen Therapie (CDK4/6i + ET) als Standard bei der First-Line-Behandl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::28e74ba3c06bc446cf560ab25f46195a
https://doi.org/10.1055/a-2008-6553
https://doi.org/10.1055/a-2008-6553
Autor:
Tobias, Engler, Peter A, Fasching, Diana, Lüftner, Andreas D, Hartkopf, Volkmar, Müller, Hans-Christian, Kolberg, Peyman, Hadji, Hans, Tesch, Lothar, Häberle, Johannes, Ettl, Markus, Wallwiener, Matthias W, Beckmann, Alexander, Hein, Erik, Belleville, Sabrina, Uhrig, Pauline, Wimberger, Carsten, Hielscher, Christian M, Kurbacher, Rachel, Wuerstlein, Michael, Untch, Florin-Andrei, Taran, Hans-Martin, Enzinger, Petra, Krabisch, Manfred, Welslau, Michael, Maasberg, Dirk, Hempel, Michael P, Lux, Laura L, Michel, Wolfgang, Janni, Diethelm, Wallwiener, Sara Y, Brucker, Tanja N, Fehm, Andreas, Schneeweiss
Publikováno v:
Geburtshilfe und Frauenheilkunde. 82:1055-1067
Background Comprehensive data from prospective clinical trials have led to a high level of evidence establishing CDK4/6 inhibitors in combination with endocrine treatment (CDK4/6i + ET) as a standard for the treatment of HER2-negative, hormone recept
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2b025963af12454faef60ebf08259e4
https://doi.org/10.1055/a-1880-0087
https://doi.org/10.1055/a-1880-0087
Autor:
Hanna Huebner, Matthias Ruebner, Christian Kurbacher, Peyman Hadji, Andreas D. Hartkopf, Michael P. Lux, Jens Huober, Sabrina Uhrig, Florin-Andrei Taran, Friedrich Overkamp, Hans Tesch, Lothar Häberle, Diana Lüftner, Markus Wallwiener, Volkmar Müller, Matthias W. Beckmann, Alexander Hein, Erik Belleville, Michael Untch, Wolfgang Janni, Tanja N. Fehm, Hans-Christian Kolberg, Diethelm Wallwiener, Sara Y. Brucker, Andreas Schneeweiss, Johannes Ettl, Peter A. Fasching, Laura L. Michel
Publikováno v:
Breast cancer research and treatment. 197(2)
Purpose The PRAEGNANT study is a registry study for metastatic breast cancer patients, focusing on biomarker detection. Recently, within this study, genetic alterations in 37 breast cancer predisposition genes were analyzed and genetic findings were
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36e3204912d602a6bda092e369bd9234
https://pubmed.ncbi.nlm.nih.gov/36409394
https://pubmed.ncbi.nlm.nih.gov/36409394
Autor:
Arif B. Ekici, Michael Untch, Matthias Rübner, Steven N. Hart, Matthias W. Beckmann, Kun Y. Lee, Volkmar Müller, Bernhard Volz, Erik Belleville, Markus Wallwiener, Tanja Fehm, Pauline Wimberger, Friedrich Overkamp, Chunling Hu, Diana Lüftner, Peter A. Fasching, Peyman Hadji, Sabrina Uhrig, Arndt Hartmann, Hans Christian Kolberg, Marius Wunderle, Diethelm Wallwiener, Andreas Schneeweiss, Wolfgang Janni, Hans Tesch, Florin Andrei Taran, André Reis, Fergus J. Couch, Sara Y. Brucker, Rohan Gnanaolivu, Siddhartha Yadav, Michael P. Lux, Johannes Ettl, Lothar Häberle, Andreas D. Hartkopf, H Hübner, Eric C. Polley
Publikováno v:
J Clin Oncol
PURPOSE Among patients with metastatic breast cancer (mBC), the frequency of germline mutations in cancer susceptibility genes and the clinical relevance of these mutations are unclear. In this study, a prospective cohort of patients with mBC was use
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69e6ca1ffd7d679c2e5ac4bc49025175
https://europepmc.org/articles/PMC8274805/
https://europepmc.org/articles/PMC8274805/
Autor:
Volkmar Müller, Alexander Hein, Andreas D. Hartkopf, Peter A. Fasching, Hans-Christian Kolberg, Peyman Hadji, Hans Tesch, Lothar Häberle, Johannes Ettl, Diana Lüftner, Markus Wallwiener, Matthias W. Beckmann, Andreas Schneeweiss, Erik Belleville, Sabrina Uhrig, Pauline Wimberger, Carsten Hielscher, Julia Meyer, Lena A. Wurmthaler, Christian M. Kurbacher, Rachel Wuerstlein, Michael Untch, Wolfgang Janni, Florin-Andrei Taran, Michael P. Lux, Diethelm Wallwiener, Sara Y. Brucker, Tanja N. Fehm, Laura L. Michel
Publikováno v:
European journal of cancer (Oxford, England : 1990). 172
Patients with de novo metastatic breast cancer (dnMBC) may have different clinical and pathological characteristics. In studies concerned with first-line metastatic patients, the proportion of these patients without secondary resistance mechanisms ma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5381376a41171712ae85184a0ca56007
https://pubmed.ncbi.nlm.nih.gov/35728342
https://pubmed.ncbi.nlm.nih.gov/35728342
Autor:
Tanja Fehm, Rachel Wuerstlein, Christoph Thomssen, Wolfgang Janni, Pauline Wimberger, Hans Tesch, Carla E. Schulmeyer, Bernhard Volz, Florin-Andrei Taran, Johannes Ettl, Sabrina Uhrig, Friedrich Overkamp, Peyman Hadji, Christian M. Kurbacher, Michael P. Lux, Carsten Hielscher, Sara Y. Brucker, Hans-Christian Kolberg, Diana Lüftner, Matthias W. Beckmann, Andreas Schneeweiss, Michael Untch, Elena Laakmann, Lothar Häberle, Volkmar Müller, Markus Wallwiener, Erik Belleville, Andreas D. Hartkopf, Julius Emons, Diethelm Wallwiener, Peter A. Fasching
Publikováno v:
Geburtshilfe und Frauenheilkunde. 80:e289-e289
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::46829f51b8cda3cc6ba60ae2f41711e7
https://doi.org/10.1055/a-1306-7231
https://doi.org/10.1055/a-1306-7231
Publikováno v:
Communications in Computer and Information Science ISBN: 9783319278681
MODELSWARD (Revised Selected Papers)
MODELSWARD (Revised Selected Papers)
Software engineering is a highly integrative computer science discipline, combining a plethora of different techniques to increase the quality of software development as well as the resulting software. The three sub-disciplines Model-Driven Software
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::55f5506b832d5ae5df5ac40b5773def0
https://doi.org/10.1007/978-3-319-27869-8_2
https://doi.org/10.1007/978-3-319-27869-8_2